Back to results
RecruitingN/A

Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker in the Management of Patients With Acute Heart Failure

NCT04554277

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Lapeyronie Hospital

Montpellier, Occitanie, France

+11 additional locations

Contact

Jean-Paul CRISTOL, MD, PhD

(0)4 67 33 83 14jp-cristol@chu-montpellier.fr
View on ClinicalTrials.gov